BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 1531004)

  • 1. Curative resection in Zollinger-Ellison syndrome. Results of a 10-year prospective study.
    Norton JA; Doppman JL; Jensen RT
    Ann Surg; 1992 Jan; 215(1):8-18. PubMed ID: 1531004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome.
    Alexander HR; Fraker DL; Norton JA; Bartlett DL; Tio L; Benjamin SB; Doppman JL; Goebel SU; Serrano J; Gibril F; Jensen RT
    Ann Surg; 1998 Aug; 228(2):228-38. PubMed ID: 9712569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of gastrinoma in the era of proton pump inhibitors.
    Banasch M; Schmitz F
    Wien Klin Wochenschr; 2007; 119(19-20):573-8. PubMed ID: 17985090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the use of routine duodenotomy (DUODX) affect rate of cure, development of liver metastases, or survival in patients with Zollinger-Ellison syndrome?
    Norton JA; Alexander HR; Fraker DL; Venzon DJ; Gibril F; Jensen RT
    Ann Surg; 2004 May; 239(5):617-25; discussion 626. PubMed ID: 15082965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible primary lymph node gastrinoma: occurrence, natural history, and predictive factors: a prospective study.
    Norton JA; Alexander HR; Fraker DL; Venzon DJ; Gibril F; Jensen RT
    Ann Surg; 2003 May; 237(5):650-7; discussion 657-9. PubMed ID: 12724631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the localization and surgical management of duodenal gastrinomas.
    Lawton GP; Modlin IM
    Curr Opin Gen Surg; 1994; ():131-7. PubMed ID: 7583948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Zollinger-Ellison syndrome].
    Fendrich V; Bartsch DK; Langer P; Zielke A; Rothmund M
    Chirurg; 2005 Mar; 76(3):217-26. PubMed ID: 15688179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization, malignant potential, and surgical management of gastrinomas.
    Kisker O; Bastian D; Bartsch D; Nies C; Rothmund M
    World J Surg; 1998 Jul; 22(7):651-7; discussion 657-8. PubMed ID: 9606277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of perioperative and postoperative control of acid hypersecretion in patients with Zollinger-Ellison syndrome undergoing gastrinoma resection.
    Fraker DL; Norton JA; Saeed ZA; Maton PN; Gardner JD; Jensen RT
    Surgery; 1988 Dec; 104(6):1054-63. PubMed ID: 2904182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of gastrinoma localization and resection in patients with Zollinger-Ellison syndrome.
    Norton JA; Doppman JL; Collen MJ; Harmon JW; Maton PN; Gardner JD; Jensen RT
    Ann Surg; 1986 Oct; 204(4):468-79. PubMed ID: 3532971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of surgery in patients with negative imaging and sporadic Zollinger-Ellison syndrome.
    Norton JA; Fraker DL; Alexander HR; Jensen RT
    Ann Surg; 2012 Sep; 256(3):509-17. PubMed ID: 22868363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome.
    Frucht H; Howard JM; Stark HA; McCarthy DM; Maton PN; Gardner JD; Jensen RT
    Am J Med; 1989 Nov; 87(5):528-36. PubMed ID: 2573280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization and resection of gastrinomas in Zollinger-Ellison syndrome.
    Vogel SB; Wolfe MM; McGuigan JE; Hawkins IF; Howard RJ; Woodward ER
    Ann Surg; 1987 May; 205(5):550-6. PubMed ID: 3579402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery to cure the Zollinger-Ellison syndrome.
    Norton JA; Fraker DL; Alexander HR; Venzon DJ; Doppman JL; Serrano J; Goebel SU; Peghini PL; Roy PK; Gibril F; Jensen RT
    N Engl J Med; 1999 Aug; 341(9):635-44. PubMed ID: 10460814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome.
    Pisegna JR; Norton JA; Slimak GG; Metz DC; Maton PN; Gardner JD; Jensen RT
    Gastroenterology; 1992 Mar; 102(3):767-78. PubMed ID: 1537514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of intraoperative methods to diagnose and resect duodenal gastrinomas.
    Sugg SL; Norton JA; Fraker DL; Metz DC; Pisegna JR; Fishbeyn V; Benya RV; Shawker TH; Doppman JL; Jensen RT
    Ann Surg; 1993 Aug; 218(2):138-44. PubMed ID: 8342993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic aspects of gastrinomas in patients with Zollinger-Ellison syndrome with and without multiple endocrine neoplasia type I.
    Pipeleers-Marichal M; Donow C; Heitz PU; Klöppel G
    World J Surg; 1993; 17(4):481-8. PubMed ID: 8103250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reoperative surgery in sporadic Zollinger-Ellison Syndrome: longterm results.
    Grobmyer SR; Vogel SB; McGuigan JE; Copeland EM; Hochwald SN
    J Am Coll Surg; 2009 May; 208(5):718-22; discussion 722-4. PubMed ID: 19476823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duodenal gastrinomas, duodenotomy, and duodenal exploration in the surgical management of Zollinger-Ellison syndrome.
    Thompson NW; Pasieka J; Fukuuchi A
    World J Surg; 1993; 17(4):455-62. PubMed ID: 8103249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surgical therapy of gastrinoma with associated Zollinger-Ellison syndrome].
    Schröder W; Hölscher AH; Beckurts KT; Schusdziarra V; Höfler H; Siewert JR
    Z Gastroenterol; 1996 Aug; 34(8):465-72. PubMed ID: 8967120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.